CT Option for Varian’s Respiratory Gating System

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 8
Volume 9
Issue 8

PALO ALTO, Calif–Varian Medical Systems, Inc. has been given the go-ahead to begin marketing the new CT Option for its RPM (Real-time Position Management) Respiratory Gating System. The FDA determined that it is a class 1 device exempt from premarket notification requirements.

PALO ALTO, Calif–Varian Medical Systems, Inc. has been given the go-ahead to begin marketing the new CT Option for its RPM (Real-time Position Management) Respiratory Gating System. The FDA determined that it is a class 1 device exempt from premarket notification requirements.

Respiratory gating is a technique for making cancer radiotherapy more accurate and effective by adjusting for tumor movements caused by breathing. The Varian system “gates” or turns off the radiation beam when a tumor in the chest and abdomen moves outside a prescribed target area.

The CT Option extends respiratory gating to the CT scanner so that images acquired for treatment planning can be synchronized with the respiratory cycle. It is available as a component for Varian’s Clinac EX Platinum accelerator or as an upgrade to the company’s Clinac C series accelerators.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Related Content